Clinical Trials

Home

My Story

Stem Cell Transplant

One Year Update

View Point

Advocacy

Clinical Trials

NJSCREF.org

List of Treatable Diseases

Current News

Guest Columnist

Funding

Readings

Transplant Survivors
Wrinkles Health Monitoring Equipment
         


October, 2006: The SCOT trial is advertising 
an alternative treatment for Scleroderma sufferers. 
It is currently being offered in many states, and 
patients are running to find out about it. Before 
you do, there are some facts you should know before 
considering this trial.
 
In 2004, investigators in the SCOT trial published 
Phase I outcomes showing a 30% mortality rate*.  
Since then there have been no additional Phase I 
data published by them to inform patients or 
rheumatologists of the Phase I outcomes. 

There is real concern since the SCOT trial uses 
Total Body Irradiation as part of their protocol. 
It is not easily noticed in the description of 
the protocol in their pamphlet, but it is a major 
part of the procedure. They claim they are 
shielding the lungs and the kidneys,due to the 
learning curve from recent data, but radiation, 
by virtue of its definition, goes where it wants. 
Total body irradiation makes Scleroderma worse. 
The "T" cells, are already over activated by 
Scleroderma.

 To reduce the high mortality rate, The SCOT 
trial has considerably  narrowed the qualification 
process to enter their trial.  If you have lung 
disease,watermelon stomach, are takings certain drugs 
for your treatment to this point, and other 
situations,  you most likely will be rejected 
as a candidate. This skews the data, masking the 
danger of the radiation to anyone who undergoes the 
treatment, even further. 

What is most disturbing is that patients--rejected 
or not--are not being told that another trial exists.  
In fact,in many cases they are being told that the 
only other way to get a transplant is to go to Europe. 
The SCOT people know this is not true.  

There is another trial called ASSIST, 
which does not use total body irradiation and is safe 
for patients with  lung involvement  and other forms 
of the disease. Patients cannot make an informed 
decision with only partial information.  A protocol 
called ASTIS, similar to ASSIST is used widely in 
Europe, with very good results, including a zero 
mortality rate.  


Let's look at the facts:  The ASSIST trial does not use 
Total Body Irradiation and has a zero* mortality rate.  
The SCOT trial does use TBI, and as of 2004 with no 
current data, has a 30% mortality rate*.  It could be 
higher.  We do not know.  This information is being 
withheld from the patients. I researched the latest 
SCOT data, and could not find any mortality rates listed 
from 2004 on.They have also removed the 2004  
publication from the Internet.

If you are approached about the viability  
as a potential candidate to the SCOT trial, ask 
about the mortality rate.  Ask about the dangers 
of radiation. Persist until you have answers with 
which you are comfortable.  Ask your doctors about 
the ASSIST trial.  You will probably get a negative 
response from them.  This may be due to ignorance or 
because they have chosen to be part of the SCOT 
program. Persist.  Do not do anything until you are 
satisfied with the information you receive.  It is
YOUR LIFE. You are entitled to all the information 
there is.   
  
Many revered medical institutions all over the 
country are turning away from the SCOT trial 
because of its radiation danger.  Consider looking 
at the ASSIST trial.
  
There is a real controversy here.  Nevertheless, 
ethically, professionally, responsibly, morally, 
the patients need to be made aware of the potential 
hazards  and all the options open to them so that 
they can make informed decisions for themselves. The 
onlyway one can do that is to study BOTH protocols side 
by side.   This is not about money or egos. It is about 
the safety of  patients. 


* In November I was taken to task by a doctor from the 
SCOT trial for my information. He told me my information 
was innaccurate, and misleading. He told me I had to point 
out that ASSIST had one death.  So, to be fair, I am stating 
that information.  It was nearly 5 years ago, it was 
disease related, but there does not seem to be evidence 
that it was transplant related. I have since rechecked 
my information.  My reporting is correct. SCOT has since 
published data stating their mortality rate is 23%. 
One has to conclude that  this is related to the narrow 
inclusion requirement. 

I told the SCOT doctor that if he wished,I would put the 
SCOT protocol and testimonials on the site, in a further 
effort to be fair.  My excluding their information has 
not been fair. 
 
To date,  I have received no protocol or testimonal.

The offer still stands.

I can be contacted for 
more information at: advocate at this address. 


*    *      *     *     *    *    *    *   *

      
A clinical trial is a study of how well a protocol 
performs on a certain part of the population before 
it is released  into the public at large.  These trials 
come in many forms.  But people are needed to help 
researchers get this information out to the public.  
This is where you come in. You can go to 
www.clinicaltrials.gov, put in your diagnosis, 
and a screen will come up listing the different trials 
for that disease.  You can read about many different 
protocols for your specific disease and the hospital 
and group of doctors who are performing that procedure.  
There could be more than one procedure.  There was 
in my case.  It did matter in my situation which  trial 
I used since I have pulmonary involvement.  Your physician 
should be able to help you decide on the best trial 
according to your condition.

Some of the trials  have already been approved by the 
FDA.  For other diseases, the trials are not yet open.  
You will have to keep trying and keep looking in 
some cases.  This is not to cause frustration  to you, 
but to give  you hope.  You can take this information 
to your doctor and then  you can make decisions together.  
You will find that the more informed you are, the more 
likely your doctor will be to consider the information.    
 
The clinical trial may not be for you.  The stem cell 
transplant may not be for you.  But you must be your own 
advocate.  You must trust your inner feelings and if you 
think this is right for you, you should go for it. 
It is ultimately your decision, it is your body.   If
you do not make the call, you will never know.